000403.SHE · Pacific Shuanglin Bio-pharmacy Co., LTD

-

-

Please sign in to comment on 000403.SHE

1 Comment

Admin
4 years, 8 months ago

Pacific Shuanglin Bio-pharmacy Co., Ltd is currently in a long term downtrend where the price is trading 13.7% below its 200 day moving average.

From a valuation standpoint, the stock is 116.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 20.8.

Pacific Shuanglin Bio-pharmacy Co., Ltd's total revenue sank by 14.6% to $235M since the same quarter in the previous year.

Its net income has increased by 23.2% to $41M since the same quarter in the previous year.

Finally, its free cash flow fell by 41.3% to $39M since the same quarter in the previous year.

Based on the above factors, Pacific Shuanglin Bio-pharmacy Co., Ltd gets an overall score of 1/5.












© PyInvesting 2025

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy